ontozry
angelini pharma s.p.a - cenobamate - epilepsi - antiepileptika, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.
danitron 5 sc suspensionskoncentrat
nordisk alkali - fenpyroximat - suspensionskoncentrat - 53 g/l fenpyroximat
orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasmer - endokrine terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
evo-conti 170+50mikrog/24timer depotplastre
theramex ireland limited - estradiolhemihydrat, norethisteronacetat - depotplastre - 170+50mikrog/24timer
evo-sequi depotplastre
theramex ireland limited - estradiolhemihydrat, norethisteronacetat - depotplastre
femanor 1+2 mg filmovertrukne tabletter
sandoz a/s - estradiolhemihydrat, norethisteronacetat - filmovertrukne tabletter - 1+2 mg
naltrexone "poa pharma" 50 mg filmovertrukne tabletter
poa pharma scandinavia ab - naltrexonhydrochlorid - filmovertrukne tabletter - 50 mg
systen conti 170+50mikrog/24timer depotplastre
paranova danmark a/s - estradiolhemihydrat, norethisteronacetat - depotplastre - 170+50mikrog/24timer
campral 333 mg enterotabletter
merck sante s.a.s. - acamprosatcalcium - enterotabletter - 333 mg
campral 333 mg enterotabletter
paranova danmark a/s - acamprosatcalcium - enterotabletter - 333 mg